Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
Enanta Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.06M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.11M | -24.6M | -24.02M | -22.05M | -8.33M |
Depreciation & Amortization | 2.65M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K | 823K | 834K | 871K |
Stock-Based Compensation | 4.69M | 5.67M | 7.72M | 5.42M | 5.56M | 8.1M | 6.72M | 7M | 7.36M | 7.14M | 6.83M | 7.6M | 6.47M | 6.06M | 5.35M | 5.47M | 5.28M | 4.88M |
Other Working Capital | 1.7M | 1.8M | 8.72M | 2.68M | 1.45M | -6.27M | 4.85M | 290K | 5.57M | -11.01M | 274K | -522K | -7.25M | 15.66M | 282.85M | 292.53M | 401.6M | 1.05M |
Other Non-Cash Items | -293K | -1.18M | 1.06M | -823K | -279K | 786K | -7.17M | 519K | -1.04M | -339K | -30K | 146K | 54K | -474K | -71K | -2.19M | -213K | -1.02M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 274K | 79K | -1.45M | n/a | n/a | n/a | n/a | n/a | 546K | 345K | 560K | 525K | 431K |
Change in Working Capital | 2.11M | 113K | 9.16M | 2.69M | -3.35M | -1.38M | 6.21M | -1.23M | 17.01M | -13.97M | 3.36M | -6.37M | -130K | 9.93M | -2.85M | -10.15M | 11.04M | -11.72M |
Operating Cash Flow | -13.49M | -16.8M | -10.4M | -14.78M | -28.6M | -24.99M | -21.6M | -32.13M | -13.78M | -35.64M | -15.53M | -29.6M | -26.38M | -13.27M | -21.02M | -29.51M | -4.58M | -14.89M |
Capital Expenditures | -2.54M | -8.74M | -8.95M | -6.54M | -1.67M | -787K | -1.37M | -2.15M | -2.38M | -3.16M | -1.44M | -251K | -74K | -363K | -33K | -399K | -130K | -188K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 12.33M | n/a | 143.6M | -49.15M | -36.73M | -29.67M | -16.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -55.02M | n/a | 1K | -95.15M | -65.29M | -146.84M | -106.12M | -176.65M | -23.25M | -67.38M | -8.73M | -38.08M | -61.73M | -62.9M | 601K | -136.36M | -66.91M | -104.67M |
Sales Maturities Of Investments | 53.19M | 77.65M | 28.02M | 95.35M | 125.58M | 134.51M | 119.32M | 33.05M | 72.4M | 104.1M | 38.4M | 54.55M | 26.75M | 108.77M | 72.11M | 93.06M | 92.5M | 87.42M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -12.33M | n/a | n/a | 49.15M | 36.73M | 29.67M | 16.47M | -34.98M | 45.86M | 72.72M | -43.31M | 25.59M | -17.26M |
Investing Cash Flow | -4.37M | 68.9M | 19.07M | -6.34M | 58.62M | -13.12M | 11.84M | -145.75M | 46.77M | 33.57M | 28.23M | 16.22M | -35.05M | 45.5M | 72.68M | -43.7M | 25.46M | -17.45M |
Debt Repayment | n/a | -4.94M | -7.26M | n/a | n/a | -7.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -183K | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | -534K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6.89M | -137K | -19K | -6.67M | -6.46M | -183K | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K | 686K | 1.15M | 299K |
Financial Cash Flow | -6.89M | -4.99M | -7.21M | -6.65M | -6.41M | -7.35M | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K | 686K | 1.15M | 299K |
Net Cash Flow | -24.74M | 47.12M | 1.46M | -27.77M | 23.61M | -45.45M | -9.79M | 22M | 30.95M | -1.77M | 15.63M | -9.26M | -58.08M | 41.86M | 52.6M | -72.53M | 22.03M | -32.04M |
Free Cash Flow | -16.03M | -25.55M | -19.35M | -21.32M | -30.27M | -25.77M | -22.97M | -34.28M | -16.17M | -38.8M | -16.97M | -29.85M | -26.45M | -13.63M | -21.05M | -29.91M | -4.71M | -15.08M |